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Abstract
Background There is interest in interventions that provide support
for patients facing challenging decisions, such as the choice between
mastectomy and breast conservation surgery for breast cancer.
However, it is diﬃcult to implement these interventions. One
potential source of resistance is the attitudes of clinicians.
Objective To examine specialist breast clinicians opinions about
the provision of decision support interventions (DesIs) for patients.
Methods As part of the development of a web-based DesI (Bres-
Dex), semi-structured interviews were conducted with specialist
clinicians [breast surgeons, breast care nurses (BCNs) and oncolo-
gists] from four breast units in a UK region, and speciality national
opinion leaders. Interviews were recorded, transcribed and analysed
using the Framework approach.
Results A majority of the 24 clinicians interviewed did not have a
working knowledge of DesIs and were ambivalent or sceptical. Many
expressed conﬂicting opinions: they noted the potential beneﬁts, but at
the same time expressed reservations about information overlap,
overload and about content that they considered inappropriate.Many
wanted access to DesIs to be always under clinical supervision. In
particular, theywere uncertain as regards howDeSIs could be tailored
to individual patients needs and also accommodate clinical practice
variation. BCNs were particularly concerned that DesIs might induce
patient anxiety and replace their role.
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Conclusions The concept of providing interventions to support
patients in decision-making tasks generated concern, defensiveness
and scepticism. These attitudes will be a signiﬁcant barrier.
Implementation eﬀorts will need to recognize and address these
issues if these interventions are to become embedded in clinical
practice.
Background
Providing choices to patients has become an
increasing priority of health service providers in
the last decade, with the hope it will improve
equity in healthcare service and delivery,1,2
enhance the process of care,3,4 and optimize
both patients psychological recovery4–9 and
treatment satisfaction.3,4,10 The successful
involvement of patients in decision-making
requires the provision of choices along with an
explanation as to why they are being oﬀered a
role in decision-making,11 together with the
provision of high quality information11,12 and
suﬃcient time to deliberate the options.
Patient Decision Support Interventions
(DesIs),13 also known as decision aids or deci-
sion support technologies, are designed to help
people make speciﬁc and deliberative choices
among options by providing (at the minimum)
information about the options and outcomes
that are relevant to a persons health status.14
The addition of DesIs to routine clinical practice
has been associated with enhanced patient
involvement in healthcare decision-making;15,16
with improved knowledge and risk perceptions,
decisions which were more consistent with
patients personal values, improved patient sat-
isfaction with decision-making15,16 and
enhanced quality of life.16 DesIs could facilitate
optimisation of patients healthcare decision-
making experiences by extending information
provision and decision support currently avail-
able from clinical teams;15 supporting, but not
replacing the central relationship between the
patient and their treating clinicians.
The surgical treatment of breast cancer is a
classic example of a preference-sensitive deci-
sion in healthcare; patients preferences can
often direct treatment due to clinical equipoise,
as neither treatment option [Breast Conserva-
tion Therapy (BCT) or mastectomy] is superior
in terms of survival (in cancers up to 5 cm
diameter),17–19 physical or psychological mor-
bidity (except body image).8,20,21 Patients are
known to possess diﬀerent treatment prefer-
ences based on individual concerns and val-
ues,22–26 creating a clinical context where DesIs
are of potential value. They have been devel-
oped elsewhere for breast cancer patients facing
treatment decisions,16 but at present, one does
not exist for this UK patient group. The
development of a web-based DesI has been
proposed to improve the ﬂexibility and acces-
sibility of such interventions, and provide rele-
vance within the UK.27
Although research demonstrates potential
beneﬁts to patients of employing DesIs as
adjuncts to support patient healthcare decision-
making,15,16 little is known about clinicians
attitudes towards such technologies except that
they tend to lack awareness of DesIs.28 As
gatekeepers of patient information, awareness of
clinicians views regarding DesIs is crucial to
their successful widespread implementation into
clinical practice. Information currently available
on clinicians perceptions of the barriers and
facilitators to DesIs are mainly found within
publications about implementing shared deci-
sion-making in clinical practice, which include
some examples where DesIs were employed.29
The most frequently reported barriers included
time constraints29–31 and perceived lack of
applicability due to patient characteristics.29 The
most commonly reported facilitators included
provider motivation, and a positive impact on
both the clinical process and patient outcomes.29
The extent to which developers consult with
both patients and clinicians during the devel-
opment of DesIs varies. A systematic review of
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information in DesIs identiﬁed a total of 98
DesIs (68 treatment focused and 30 screening
focused) which speciﬁcally described the devel-
opment or implementation process.32 Appro-
ximately 80% employed external consultation
within the process, with a trend to primarily seek
expert guidance; mainly comprising small group
or panel discussions with experts or clinicians,
rather than the obtainment of more detailed
information through individual discussions.
The successful implementation of DesIs into
routine practice is likely to require not only
adherence to quality criteria, as established by
the International Patient Decision Aid Stan-
dards (IPDAS),33 but for clinicians to accept and
embrace such technologies.28,34 The aim of this
study was to explore individual specialist clini-
cians views of the design, acceptability and
implementation of a DesI for UK women with
breast cancer eligible for a choice of therapeutic
surgery; seeking specialists perceptions of DesIs
in general, their impression of web-based ver-
sions and the employment of DesIs within ther-
apeutic breast cancer surgery. We conducted this
study as part of the BresDex project: developing
a web-based decision support for women oﬀered
surgical options for breast cancer.
Methods
Study design
Qualitative methods were employed to explore
the views of specialist breast clinicians regarding
the design and acceptability of a DesI for women
with breast cancer, in whom BCT is not con-
traindicated. Semi-structured interviews were
chosen for their capacity to capture rich data on
topics of pre-determined interest, while provid-
ing suﬃcient ﬂexibility to identify emergent
themes in allied areas of interest.
Sample and setting
Approval to conduct the study was obtained
from the Multicentre Research Ethics Com-
mittee of Wales, local research ethics and NHS
Trust research governance committees. Thirty
seven eligible specialist breast clinicians were
invited to participate in the study; including
thirty-three clinicians from four breast units
within a UK region and four national opinion
leaders with expertise in the surgical, oncologi-
cal and psycho-oncological management of
breast cancer. Eligibility was based on
the inclusion and exclusion criteria outlined
below.
Inclusion criteria
• Willingness to be interviewed about this area
of clinical practice.
• Experience of consultation with women facing
breast cancer treatment decisions or expertise in
the management and decision-making experi-
ences of women with breast cancer.
Exclusion criteria
• Clinicians who were not permanent specialist
members of a multi-disciplinary breast team.
• Clinicians not routinely involved in discussing
breast cancer treatment decisions with patients
or those lacking expertise in the ﬁeld.
The semi-structured interview topic guide was
developed collaboratively by the multidisciplin-
ary research team, including three specialist
breast team clinicians [two surgeons and one
breast care nurse (BCN)], two academic general
practitioners, four non-clinical researchers, two
National Breast Screening Programme repre-
sentatives and a consumer representative who
had previously been treated for breast cancer.
The topic guide explored clinicians opinions and
experiences of decision-making among UK
women with breast cancer given a choice of
surgery, and their opinions regarding the design,
acceptability and implementation of a DesI,
including the scope, content and administration
of such an intervention. As part of the interview,
clinicians were given a synopsis of what DesIs
are, and were shown a paper copy of an early
prototype of BresDex to stimulate discussion.
Interviews were digitally recorded and tran-
scribed verbatim. All data were anonymised and
stored securely.
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Data analysis
Qualitative data analysis followed the National
Centre for Social Researchs Framework
Analysis.35 This rigorous, comprehensive, sys-
tematic approach is particularly suited to the
analysis of qualitative health services data,
where the research questions are more directed
and goal oriented than with other forms of
qualitative research. Analysis proceeded through
the stages of familiarization, identiﬁcation of a
thematic framework, charting, mapping and
data interpretation.35
Results
Of the thirty-seven specialist clinicians approa-
ched, twenty-ﬁve agreed to participate in the
study. The non-participants comprised eight
BCNs, three surgeons and one surgeon opinion
leader. In addition, one surgeon agreed to par-
ticipate, but later withdrew due to interview
scheduling diﬃculty. Interviews were undertaken
over a seven-month period from May to
November 2008 with 24 specialist breast clini-
cians, 21 NHS breast team clinicians (seven con-
sultant surgeons, nine BCNs, four oncologists
and one radiotherapy technician), and three
national opinion leaders (a consultant surgeon,
oncologist and nurse consultant). The interviews
were conducted in the clinicians work environ-
ment by two non-clinical researchers (KC and
KW) and varied in length between 25 and 60 min.
The clinicians interviewed had very limited
pre-existing knowledge or experience of patient
DesIs. Despite this, most were generally positive
about such interventions and regarded them as
potentially useful in enhancing both the infor-
mation provided and the decision-making sup-
port oﬀered by clinicians.
Many felt, however, that this type of decision
support was only likely to beneﬁt speciﬁc patient
groups, particularly those ﬁnding decision-
making challenging and who also had suﬃcient
technological skills to use a computer or access a
web-based system. Clinicians also expressed the
view that to be of use, the DesI would need to be
designed and developed sensitively and always in
conjunction with clinicians and patients, and
evaluated among the intended patient group
prior to dissemination.
The interviews generated ﬁve main themes;
views about the nature and quantity of content
information in a DesI for breast cancer surgical
options, views about which information should
be omitted from the decision support, views
about the presentation style, the introduction
and exact mode in which patients used DesIs,
and the perceived challenges to the implemen-
tation of a DesI into clinical settings. In addition
to perceived implementation challenges, clini-
cians conceptualized a number of challenges
related to content and accessibility, which are
detailed within the other themes and summa-
rized in Table 1.
Clinicians views about the nature and
quantity of content information in a DesI for
breast cancer surgical options.
The clinicians felt it important that the infor-
mation to be included should be organized
around four main headings; treatment options,
factual content, patient experience video clips
and photographic images.
Treatment options
All clinicians expressed the view that a breast
cancer surgeryDesI should primarily focus on the
most relevant treatment options that patients
need to consider: BCT ormastectomy.Many also
felt that immediate and delayed breast recon-
struction should probably be included, alongwith
basic informationonneo-adjuvant chemotherapy
to increase the potential scope of BCT.
Clinicians, however, expressed the view that
the range of possible techniques involved in both
BCT and breast reconstruction could pose a
potential problem in terms of the locally avail-
able options, treatment descriptions and poten-
tial outcomes.
…[the DesI] is potentially going to a bit provoca-
tive…because…We have all got our own ways of
doing it [BCT]. Some…do a wide local excision
leave a big dent, some…think much more carefully
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[about] placement of scars,…breast reshap-
ing…using advanced onco-plastic techniques. So
how are you going to cover all that? And if you do,
are you going to have patients coming along say-
ing…I want it done like that, to a surgeon who is
not able to oﬀer them that. (HCPCD014, Con-
sultant Breast Surgeon, Opinion Leader)
Factual content
Most clinicians felt the DesI should provide core
information about BCT and mastectomy, with
or without immediate reconstruction, including
their possible advantages and disadvantages.
I think you have got to say the advantages and
disadvantages of breast conservation, advanta-
ges…overall survival is the same…you can get a
very good cosmetic result…Disadvantages…a
higher local recurrence rate, which may require
further treatment… (HCP012, Consultant Breast
Surgeon)
Almost all vocalized the opinion that the DesI
should include clear, concise unambiguous
information on recurrence rates.
…if you [are]…going [put] something in there about
the risk of a recurrence. That has to be put in a very
unambiguous terminology…very easy to under-
stand so you cant switch the ﬁgures round and
make a risk soundworse than it is, or leave anything
open to misinterpretation… (HCP002, BCN)
Some, however, felt that the presentation of
recurrence data was not particularly straight-
forward due to the complexity and variability of
the data and that this lack of clarity might
inﬂuence patients decisions.
I think the single biggest challenge for a DesI that I
dont think people get told about at the moment is
that the rate of local recurrence is double if you have
lumpectomy and radiotherapy than it is if you have
mastectomy…[but] overall, the survival rate is the
same or there is some survival beneﬁt from radio-
therapy at ﬁfteen years, but that tends to be…where
the recurrence rates are high…but…one in four
recurrences results eventually in a metastasis and
death, and so if you have a higher local recur-
rence…which you do in breast conservation, there
may be a small excess mortality from that. I dont
think many people are talking about that because if
you do you push everyone towards mastectomy.
(HCP012, Consultant Breast Surgeon)
Several clinicians felt that the intervention
should include an outline of the diﬀerent breast
reconstruction options available. They also
expressed the view that patients needed to
understand that reconstructive procedures are
Table 1 Clinicians perceived challenges to DesIs
Content
Which treatment options to include
Level of information detail
The inclusion ⁄ type of survival and prognosis data
The inclusion of photographic images
How to accommodate heterogeneity of clinical practice
How to tailor to patient and information need heterogeneity
Accessibility
Potentially constrained by clinicians willingness to inform patients about the DesI
Potentially constrained by patients technological skills, and computer or internet access
Implementation
Clinician reservations and uncertainty of how DesIs can assist patient decision-making in the context of pre-existing
information resources and sources of decision support
Clinician concern that a DesI might cause information overload
Clinician concern that a DesI could cause patient distress (especially photographic images and prognostic data)
The correct identiﬁcation of patients to receive a DesI to (all patients given a choice or only those actively seeking a role
in choosing their treatment)
Timing of the DesI presentation to patients and potential workload implications [especially breast care nurses (BCNs)]
Clinician concern that DesIs could be perceived as a potential replacement for the highly specialized BCN role
Clinician concern regarding a DesI retaining its relevance within an area of rapidly changing clinical practice (options and
techniques)
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speciﬁcally tailored to individual patient
requirements.
…I think the things to get over are that there is
more than one way of doing it, not everybody will
be suitable for every type. (HCPCD011, Consul-
tant Breast Surgeon)
There was a general view that it would be
beneﬁcial for the DesI to include basic infor-
mation on neoadjuvant chemotherapy and
radiotherapy, including their common side
eﬀects: hair loss, nausea and vomiting, infertility
and infection risks for chemotherapy; tiredness,
skin soreness and breakdown, potential breast
and lung ﬁbrosis, cardiac injury and a small risk
of secondary cancers for radiotherapy.
Clinicians suggested that the DesI might also
include information on usual treatment time-
lines, sexual function, psychological outcomes,
anaesthetic risks, diet, male breast cancer, clini-
cal trials and speciﬁc information for partners.
Some also wondered whether the intervention
should include information speciﬁcally designed
for ethnic minority groups and those with
learning disabilities.
Patient experience video clips
Most clinicians felt that video clips of patients
experiences would be useful inclusions within the
DesI. One felt video clips could prove parti-
cularly useful for patients with poor literacy.
Photographic patient images
Photographic images showing post operative
results were felt to be of great potential value
within the DesI for their ability to demonstrate
the range of potential aesthetic outcomes (good
to poor) for the various treatment options.
Photographs of women who have had mastecto-
mies,…wide local excision surgery [BCS]…radio-
therapy reactions…breast reconstructions,
showing good and bad results. (HCP007, Consul-
tant Breast Surgeon)
There was, however, concern expressed by
BCNs in particular that some patients accessing
such images in an unprepared state might
become distressed. These clinicians felt that
patients might beneﬁt from being warned about
the nature of such images, so that they could
decide whether to proceed, and if so, were
prepared. Alternatively, some suggested that
access to the DesI should be limited to being
under the supervision of BCNs.
Views about which information should be
omitted from the decision support
The main topic of contention was whether sur-
vival and prognosis data should be included in
the DesI. Many felt that if survival and prog-
nosis data were incorporated, it was essential
that the content was very sensitively portrayed
and should comprise only a very basic level of
information.
Clinicians generally felt that at diagnosis,
most patients simply wanted to be reassured that
they were going to survive. While clinicians were
happy reassuring women presenting with early
breast cancer about good survival data, their
concern was that the prognostic data for those
presenting with more advanced breast cancer
were a lot worse and that the provision of this
information could prove unhelpful and upset-
ting at this stage of treatment decision-making.
Most clinicians expressed the view that pro-
gnostic information was diﬃcult to commu-
nicate sensitively and ideally should only be
provided face to face by clinicians.
…patients trying to work out their prognosis
without input from the clinician is quite danger-
ous. There are web sites…but…you need a certain
amount of medical knowledge to interpret them.
They are meant to be physician tools… Patients
ﬁnd them and… sometimes can be quite shocked
by the [prognostic] information they get back….I
think thats something that should discussed
patient to doctor… (HCP006, Clinical Oncologist)
They also expressed reservations about
providing prognostic information at the time
of diagnosis and surgical decision-making;
believing it better deferred until patients post
operative pathology results were available,
therefore permitting a more accurate individu-
alized assessment of prognosis.
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…obviously we cant withhold information from
people and they do have to have a very frank
discussion about things like long term prognosis
and survival rates, but I would suggest the best
time to do that is when you see them with their
ﬁnal pathology results after the their surgery…
(HCP014, Consultant Breast Surgeon)
Views about the presentation style of a DesI
Clinicians views about the presentation style
of the DesI centred on the medium used,
language style and terminology. There was
general consensus that the medium should be
user-friendly, and that it should be written in
language which is clear, concise and free from
medical jargon.
…I do think we need to avoid…medical jargon
and…abbreviations. (HCPCD005, BCN)
Clinicians were unsure, however, as regards at
what point on the spectrum of simplicity to
complexity, the DesI should be pitched. They
also questioned how DesIs could tailor to indi-
vidual patients intelligence and pre-existing
knowledge, and their information needs.
This [DesI] has [to be]…written for a general…one
size ﬁts all, you cant tailor it that much can
you…[and] some people do want to know abso-
lutely every minute possibility and every statistic…
(HCP002, BCN)
…I think you have [to have] a core level of infor-
mation and if people want to know more they can
access additional levels. (HCP006, Clinical Oncol-
ogist)
The introduction and exact mode in which
patients used DesIs
Clinicians felt that DesIs should be introduced
to patients by their BCNs, and that they were
likely to provide the greatest potential beneﬁt
when made available at an early stage in the
process of consolidation and exploration of
information, when patients received other sup-
porting information and were starting to con-
sider their options and preferences in the light of
factual treatment information.
There was a general perception amongst cli-
nicians that patients tend to identify many issues
they want to explore regarding their cancer and
its treatment between the period of initial
information provision at diagnosis, and the
subsequent consultation with their BCN several
days later. It was therefore felt that this period
between consultations was the ideal time for
patients to utilize the DesI to reinforce the
information provided by the breast team,
expand their knowledge further and start to
explore their preferences in the context of this
knowledge. It was thought patients would then
have a more informed basis on which to have
further one-to-one treatment discussions with
their breast clinicians.
Clinicians held mixed opinions on whether
patients should be guided or supervised by a
BCN while using the DesI, or whether patients
should use it independently. Some felt that
their use should be supervised to avoid mis-
interpretation of information, and provide
support to patients who might become dis-
tressed or require technical assistance during
its use.
I think it should be used with somebody in the
room with them, I dont think it should be used
unsupervised…[or] accessed in an unsupervised
way just oﬀ the internet, because I think they
would need to have somebody sitting with them
who could talk to them about all the queries that
they are going to have. (HCP007, Consultant
Breast Surgeon)
Others acknowledged that patients might wish
to explore such decision support independently,
outside the clinical environment.
Perceived challenges to the implementation of a
DesI into clinical settings
Despite many generally positive comments
about the potentially beneﬁcial role of DesIs in
supporting patient decision-making, clinicians
also perceived challenges and expressed reser-
vations about their use. Nine main challenges to
the implementation of DesIs into practice were
identiﬁed. These are described below.
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Unnecessary addition to current information
provision and decision-making support
One of the key issues for some clinicians (pre-
dominantly BCNs) was the feeling that DesIs
would not add anything to the wealth of pre-
existing information available to this group of
patients in verbal, written and web-based forms,
and the decision support currently oﬀered by
specialist breast clinicians.
…it just doesnt seem to be adding anything to
what patients should be getting told in the clinic.
(HCPCD014, BCN)
In particular, clinicians questioned how the
DesI would diﬀer from these pre-existing
resources.
Information overload
Clinicians raised the concern that a DesI might
overwhelm patients with information. They felt
that patients were already exposed to large vol-
umes of information and had a relatively short
time to assimilate and use this for decision-
making. They were concerned that an additional
resource might detract from rather than enhance
the process.
The thing that really bothers me is they are satu-
rated with information from the surgeon, from us;
our waiting times are very short at the moment, so
the turnaround sometimes can be….diagnosis
Friday…in the theatre the following Tuesday.
They are saturated on that Friday the whole
weekend is a blur, and they have got this [DesI] to
look at as well… (HCPCD009, BCN)
Uncertainty regarding the ability of a DesI to
tailor to individual patient needs
A number of BCNs in particular expressed
that it was patronizing to think that a com-
puter- or web-based intervention could
enhance or replace the individually tailored,
two-way, face to face discussions between
clinicians and patients which informed and
supported patient decision-making. They felt
that the key to the success of the BCN role
was the ability to tailor information, commu-
nication and decision-making support to indi-
vidual patients highly speciﬁc needs.
There is a lot of skill in tailoring information to the
patient that a computer tool cant replace. I think
there is a little bit of scepticism about the useful-
ness of it…I dont think that a computerized
programme or DVD can replace a face to face
consultation… (HCP002, BCN)
…if you have got the person in front of you and
they are…becoming more visibly distressed, you
would back oﬀ, or…oﬀer emotional support…I
think there might be concern that a decision-
making tool is by its nature more…cold and clin-
ical… (HCP019, BCN opinion leader)
Uncertainty regarding the interactive decision-
making aspect of the DesI
There was also some scepticism articulated
about how the proposed interactive decision-
making component of the DesI could assist
patients decision-making process. One of the
potential interactive tools discussed was a self
ranking exercise to help patients prioritize the
most important factors driving their choice.
If I was a patient and I was asked to list these
[factors] in order of importance [to making my
decision] my number one thing of importance
would be chances of living or dying, does that help
me make a decision whether I want to keep my
breast or not? No. Because its completely irrelevant
to the surgical choices that you are being oﬀered.
Chances of cancer coming back does that help me
make a choice, well no… (HCPCD014, BCN)
How to account for variation in practice
A recurring theme was how a DesI could
accommodate for the existence of variation in
clinical practice in both the options available to
patients and the surgical techniques used. Vari-
ation in the availability and rationing of recon-
structive techniques were also viewed as
particularly problematic. Clinicians were specif-
ically concerned about how a DesI might inﬂu-
ence patients treatment expectations.
…this other issue is particularly [important] in the
smaller [breast] units…not doing reconstruc-
tion…if you are going to be…putting reconstruc-
tion much more on the agenda…how are [these]
units going to cope with the demand…
(HCPCD014, Consultant Breast Surgeon, Opinion
Leader)
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They also articulated that treatment practices
change rapidly over time and therefore this
resource would need to be regularly updated to
retain its relevance to clinical practice.
…these things go out of date very quickly so its
how you fund an updating programme for them…
(HCP012, Consultant Breast Surgeon)
Concern that patients may access information
they are unprepared for
Although clinicians agreed that patients should
not be denied information, some voiced con-
cerns that in using the DesI, patients might
encounter information that they were unpre-
pared for, which might cause distress or anxiety.
They particularly questioned whether entrance
to the more sensitive components (photo-
graphic images and prognostic data) should be
via gateways advising patients about what they
were about to access. Clinicians felt that this
would enable patients to choose actively whether
or not to view certain aspects of the DesI. Cli-
nicians, however, acknowledged that encoun-
tering material which may cause distress is an
existing possibility among patients utilizing web-
based resources.
Concern that a DesI could devalue or replace the
role of the clinician
One of the main reservations of clinicians was
that DesIs might be perceived as a standalone
intervention and thus a potential replacement
for the individualized face-to-face consultations
between clinicians and their patients. They felt
strongly that DesIs should be viewed as an
adjunct to the information and decision sup-
port provided by clinicians in verbal and other
forms.
I think some are a little worried that you are trying
to do us out of a job. But I dont think that a
computerized programme or DVD can replace a
face to face consultation… (HCP002, BCN)
BCNs were speciﬁcally concerned that the
introduction of a DesI into routine practice
might lead to a poorer quality service and
support for patients. In particular, they feared
that one result might be the replacement of the
specialist and therefore more expensive BCN,
with a less highly qualiﬁed, less expensive nurse
who would merely go through the DesI with
patients.
Time and resource implications
Clinicians expressed concern regarding the
potential time and resource implications of
implementing a DesI into routine clinical prac-
tice. Some felt that it might increase the work-
load of BCNs in particular, through the need to
introduce and explain what they were, provide
support for their use and answer additional
queries they might generate. BCNs were princi-
pally concerned that their limited resources and
time with patients might be diverted from their
established roles in the provision of information,
and both decision-making and emotional sup-
port.
Its probably going to make us more work rather
than less work…Because the vast majority of
people dont want to see you three and four times
before surgery, and I am just wondering if they
have got questions that arise from what they see on
there [the DesI], whether they will want to come
back and discuss it again… (HCPCD006, BCN)
Accessibility issues
Clinicians acknowledged that patients access to
such a DesI was unlikely to be universal. They
felt that accessibility might be constrained by a
number of factors, including clinicians deﬁni-
tions of which patients are eligible for a choice of
surgical treatment.
I know of at least one colleague nationally who will
not do mastectomy for someone who wants it if
they are eligible for lumpectomy. He will say you
have to ﬁnd another surgeon…there will always be
places,…[and] people around the country who will
not support a patient who wants a mastectomy
who is eligible for lumpectomy. So they will not
use [such] a tool [DesI]…because patients arent
being given a choice… (HCP012, Consultant
Breast Surgeon)
They also felt that patients technological
skills and access to equipment or the web would
limit the potential value of DesIs to a wider
group of patients. In particular, clinicians felt
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that older patients (especially those over 65)
were less likely to utilize such an intervention.
Several suggested that this type of accessibility
barrier could be overcome by making them
available within breast clinics, with or without
BCN support.
Discussion
Principal ﬁndings
A majority of clinicians were not aware of
developments in the ﬁeld of shared decision-
making and the increasing interest in DesIs for
patients. After being informed, most were gen-
erally ambivalent and many were either sceptical
or held negative opinions. They articulated that
such interventions might beneﬁt patients as
supplementary resources for those making
treatment decisions, but at the same time
expressed marked reservations regarding their
content and potential usefulness. Clinicians
reservations were mainly based on concerns
about how such an intervention diﬀered from
pre-existing information resources, how they
could tailor to highly speciﬁc patient needs, and
concerns that they could cause information
overload and distress. They felt that it was too
diﬃcult to develop a useful decision support for
patients due to the heterogeneity of patient
information needs and information-handling,
diverse patient web-access, and the heterogene-
ity and fast-changing nature of clinical practice.
They were also unsure of the extent and nature
of information to be included: which treatment
options, at what level of detail, whether survival
and prognosis data should be provided, and
whether photographic images of women after
surgery should be available. They did not raise
the counter-argument that some patients might
want such data and there was a general view that
access to the instrument would be governed by
clinicians willingness to inform patients about
the intervention, seemingly unaware that
patients may search for such information and
wish to know which sources they should trust.
Many expressed the view that the DesI should
not be freely available and that clinicians would
select which patients were given access. There
were also concerns about practical issues –
where and when the tool should be used – and a
possible negative impact on professional roles,
where clinicians may feel threatened by the
arrival of a web-based interactive decision sup-
port resource.
Strengths and weakness of the study
The strength of this study and method is that it
reports one of the ﬁrst studies to explore in
depth the views of clinicians who are already
actively supporting women facing the diﬃcult
choice between mastectomy and BCT. Their
critical responses are proof of how seriously they
considered the topic, and the qualitative inter-
views provided the opportunity to explore their
concerns in detail. Our study could potentially
have been improved if we had been able to
interview clinicians at many other breast units as
we know that diverse views exist on this subject.
Nevertheless, we are reassured by our analytical
methods that data saturation was achieved and
that this article represents a valid appraisal of
professionals views towards DesIs.
Results in the context of other studies
Clinicians are one of the most powerful gate-
keepers to patient information. Their views and
willingness to implement new technolo-
gies,28,32,34 together with the capacity for DesIs
to operate within the existing healthcare process
are likely to prove the critical factors in the
successful and widespread implementation of
DesIs into clinical practice. These results add
new insights to the existing literature and indi-
cate the deep professional reservations about
supporting patients to become empowered, to
become informed and to gain the ability to
participate in decision-making activities.
Implications
These results provide sobering data for those
who advocate the use of patient decision sup-
port. Many of the clinicians articulated a desire
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to control or restrict the topics of information
available to patients – speciﬁcally survival and
prognostic data, and photographic images, and
to supervise patients access to the DesI to
minimize distress and anxiety. Few clinicians
seemed to accept that their patients are likely to
increasingly search for and access information
resources outside the clinicians control.32,36
Many BCNs were also opposed to patients uti-
lizing an independent intervention to increase
knowledge or stimulate engagement in decision-
making, in the belief that the intention was to
replace their skills as patient advocates. Previous
work has emphasized many practical issues,
such as time constraints and the applicability
and speciﬁcity of DesIs.29,32,33,37–39 This study
conﬁrms that these are factors, but also high-
lights a much more important issue which
probably lies at the heart of the implementation
challenge: many clinicians do not yet fully accept
that patients are capable of becoming informed
to the level where they are able to formulate
ideas about their preferences and therefore take
part in key decisions. Understandably, many
patients actively seek additional information,
and the internet has become a popular source.40
Clinicians are rightly concerned about the
quality of such information resources and can
express a desire to protect patients from inaccu-
rate or misleading information. However, in so
doing they run the risk of appearing controlling
or defensive about their role in advising patients
about their disease and its treatment. BresDex
was designed to address these concerns by
ensuring adherence to evidence, involving all
stakeholders, undergoing a 3-year development
phase, a detailed evaluation and complying with
quality standards.
It is recognized that it is very diﬃcult to
implement DesIs into clinical practice set-
tings.37 This study reveals the extent and depth
of professional concerns about patient DesIs.
Unless developers and those wishing to
implement these interventions fully understand
and work with clinicians to address and
manage these concerns, there is very little
chance that these methods will gain ground in
clinical settings.
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